PRISM HTLV-I/HTLV-II 6E50-68

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 07 report with the FDA on 2009-09-16 for PRISM HTLV-I/HTLV-II 6E50-68 manufactured by Abbott Laboratories.

Event Text Entries

[1147732] The customer stated they have observed an increase in repeat reactive rates on the prism htlv i/ii assay since 2009. There were ten repeat reactive samples in two months, all which have not confirmed by supplemental testing at a reference laboratory. The customer stated the majority of these sample were from repeat donors who had never tested reactive previously. No impact to patient management was reported.
Patient Sequence No: 1, Text Type: D, B5


[1708172] It was reported that during a laparoscopic gastric bypass procedure, all seven trocars had excessive leakage throughout the procedure. A second insufflation machine had to be brought into the room and the pressure level was sent higher than normal. The procedure was prolonged for fifteen minutes. The same trocars were used to complete the procedure. No adverse consequences reported.
Patient Sequence No: 1, Text Type: D, B5


[8381965] This is an initial report. An investigation is in process. A final report will be submitted when the investigation is complete. An investigation is in process
Patient Sequence No: 1, Text Type: N, H10


[8785299] (b)(4) - reactivity originating from htlv-i viral lysate. Thirty of 79 prism htlv-i / htlv-ii reagent lots, list number 06e50-68, have exhibited initial reactive rates (irr) and/or repeat reactive rates (rrr) that exceed the package insert 95% confidence interval upper limit. Multiple customer complaints related to reactive rates from several sites representing various geographic areas for these lots have been received since 7/30/08. There was no impact to product functionality or product performance. The probable cause of some reagent lots exhibiting irr and/or rrr that exceed the package insert 95% confidence interval upper limit is that these clinical results were obtained from the 3 clinical lots combined and does not accurately represent the individual clinical lot irr and rrr performance. A contributing factor for the higher than expected repeat reactive rates observed at multiple customer sites for the prism htlv-i/htlv-ii assay is a sample-specific antibody interaction with the microparticle and probe components of the assay reagents. The target of this reactivity originates from the htlv-i viral lysate.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1415939-2009-01110
MDR Report Key1473835
Report Source07
Date Received2009-09-16
Date of Report2009-08-21
Date of Event2009-07-01
Date Mfgr Received2010-08-17
Device Manufacturer Date2009-03-30
Date Added to Maude2010-09-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI KONDOS RN, BSN
Manufacturer Street200 ABBOTT PARK ROAD DEPT. 09B9, AP50
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone8479375120
Manufacturer G1ABBOTT LABORATORIES
Manufacturer Street100 ABBOTT PARK ROAD
Manufacturer CityABBOTT PARK IL 60064350
Manufacturer CountryUS
Manufacturer Postal Code60064 3500
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePRISM HTLV-I/HTLV-II
Generic NameFOR DETECTION OF HTLV-I/ HTLV-II ANTIBODIES IN HUMAN SERUM OR PLASMA
Product CodeMTP
Date Received2009-09-16
Catalog Number6E50-68
Lot Number74604M100
Device Expiration Date2010-03-11
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABBOTT LABORATORIES
Manufacturer Address100 ABBOTT PARK ROAD ABBOTT PARK IL 60064350 US 60064 3500


Patients

Patient NumberTreatmentOutcomeDate
10 2009-09-16

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.